Dr. Deryl Troyer
“We focus on development of novel ways to detect cancer and the utilization of stem and defensive cells as delivery vehicles for targeted cancer therapy. We have successfully used engineered umbilical cord stem cells, neural stem cells, and monocytes to deliver cytokines to breast cancer, melanoma and pancreatic cancer in rodent models. We are currently testing these and other cells for targeted delivery of therapeutic molecules in nanoparticles to minimize off-target side effects associated with current cancer therapy. We are also loading these delivery vehicles with core/shell/shell iron/iron oxide nanoparticles for magnetic hyperthermia and imaging.
Other areas of focus include development of new animal models of cancer that will enable more rapid translation to the clinic. This work is carried out in close collaboration with Dr. Stefan Bossmann in the chemistry department at K-State.”